In conclusion, this study provides a strong support for the synergistic effect of nab-PTX combined with anti-PD-1 antibody in inhibiting tumor growth, enhancing immune responses, and suppressing Serpinc1 gene expression and emphasizes the role of Serpinc1 overexpression in cancer development. The gene discussed is PDCD1; the disease is cancer.